Matthew Shurtleff

Matthew Shurtleff has worked in various positions in the biotechnology field since 2009. In 2009, they were a Senior Research Assistant at Oregon Health and Science University (OHSU). From 2011 to 2017, they were a Graduate Student at UC Berkeley, where they studied the selective packaging of RNA into extracellular vesicles. From 2017 to 2020, they were a Postdoctoral Researcher at the University of California, San Francisco, where they established the function of the ER membrane protein complex (EMC) during early stages of multipass membrane protein biogenesis and Dengue Virus infection. Since 2020, they have been a Senior Scientist at Lycia Therapeutics, where they are the pipeline project team lead overseeing in vitro/in vivo PoC and protein engineering towards lead candidate designation. Matthew is also the new internalizing receptor discovery team lead, resulting in the addition of two receptors to Lycia's portfolio and patent filings, and the biology lead on a new target discovery team, resulting in two pipeline target promotions. Matthew has also interfaced with CROs to perform genome-wide screens, monoclonal antibody campaigns and knockin mouse model development supporting both discovery and pipeline projects.

Matthew Shurtleff received a Bachelor's degree in Microbiology, General from California Polytechnic State University-San Luis Obispo in 2006. Matthew then went on to earn a Master's degree in Biological Sciences from the same university in 2009. Finally, they completed their PhD in Microbiology at the University of California, Berkeley in 2016.